JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FTPA
3901
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
| $985K | ﹤0.01% |
+100,000
| New | +$980K |
2022 Q2
0 quarters
|
|
|
HHLA
3902
DELISTED
HH&L Acquisition Co.
HHLA
| $982K | ﹤0.01% |
+100,000
| New | +$981K |
2022 Q2
0 quarters
|
|
|
OEPW
3903
DELISTED
One Equity Partners Open Water I Corp. Class A Common Stock
OEPW
| $982K | ﹤0.01% |
+99,999
| New | +$981K |
2022 Q2
0 quarters
|
|
3904
Global Industrial
GIC
$1.66B
| $981K | ﹤0.01% |
29,025
-2,308
| -7% | -$75.5K |
2016 Q4
22 quarters
|
|
|
CSTA
3905
DELISTED
Constellation Acquisition Corp I
CSTA
| $981K | ﹤0.01% |
+99,798
| New | +$981K |
2022 Q2
0 quarters
|
|
|
FSNB
3906
DELISTED
Fusion Acquisition Corp. II
FSNB
| $981K | ﹤0.01% |
+99,999
| New | +$979K |
2022 Q2
0 quarters
|
|
|
CPUH
3907
DELISTED
Compute Health Acquisition Corp.
CPUH
| $981K | ﹤0.01% |
100,000
-153,728
| -61% | -$1.51M |
2021 Q2
4 quarters
|
|
|
LEGA
3908
DELISTED
Lead Edge Growth Opportunities, Ltd Class A Ordinary Shares
LEGA
| $981K | ﹤0.01% |
+100,000
| New | +$978K |
2022 Q2
0 quarters
|
|
3909
PUT
Paycom
PAYC
$9.96B
| $980K | ﹤0.01% |
3,500
| – | – |
2021 Q3
3 quarters
|
|
3910
Scholastic
SCHL
$666M
| $980K | ﹤0.01% |
27,254
-9,558
| -26% | -$353K |
2015 Q3
27 quarters
|
|
|
FRXB
3911
DELISTED
Forest Road Acquisition Corp. II
FRXB
| $980K | ﹤0.01% |
100,000
-135,833
| -58% | -$1.33M |
2021 Q4
2 quarters
|
|
|
FRON
3912
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
| $980K | ﹤0.01% |
100,000
-124,723
| -56% | -$1.22M |
2022 Q1
1 quarter
|
|
|
OHPA
3913
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
| $980K | ﹤0.01% |
100,000
-53,076
| -35% | -$520K |
2021 Q4
2 quarters
|
|
3914
ARKO Corp
ARKO
$468M
| $979K | ﹤0.01% |
119,869
-51,695
| -30% | -$450K |
2020 Q1
9 quarters
|
|
3915
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $979K | ﹤0.01% |
7,221
-124
| -2% | -$17.1K |
2013 Q2
36 quarters
|
|
|
RXRA
3916
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
| $979K | ﹤0.01% |
+100,000
| New | +$979K |
2022 Q2
0 quarters
|
|
|
LVRA
3917
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
| $978K | ﹤0.01% |
100,000
+50,000
| +100% | +$490K |
2021 Q4
2 quarters
|
|
|
MIT
3918
DELISTED
Mason Industrial Technology, Inc.
MIT
| $978K | ﹤0.01% |
100,000
| – | – |
2021 Q4
2 quarters
|
|
3919
PUT
Matsons
MATX
$6.91B
| $977K | ﹤0.01% |
+13,400
| New | +$1.15M |
2022 Q2
0 quarters
|
|
|
NKGN
3920
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $976K | ﹤0.01% |
100,557
| – | – |
2021 Q3
3 quarters
|
|
3921
Opendoor
OPEN
$2.37B
| $975K | ﹤0.01% |
214,085
+193,266
| +928% | +$1.27M |
2021 Q2
4 quarters
|
|
|
HCVIU
3922
DELISTED
Hennessy Capital Investment Corp. VI Unit
HCVIU
| $975K | ﹤0.01% |
100,000
| – | – |
2021 Q4
2 quarters
|
|
3923
IBEX
IBEX
$579M
| $973K | ﹤0.01% |
57,679
-5,341
| -8% | -$87.1K |
2020 Q3
7 quarters
|
|
|
RVNC
3924
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $973K | ﹤0.01% |
70,400
-146,200
| -67% | -$2.25M |
2021 Q4
2 quarters
|
|
3925
Brookfield Infrastructure Partners
BIP
$16.8B
| $972K | ﹤0.01% |
25,431
+16,296
| +178% | +$669K |
2015 Q3
27 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.